Zio XT ECG Monitoring System vs Merlin.net

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by iRhythm Technologies
VS
by Abbott (formerly St. Jude Medical)

AI Verdict

Zio XT is designed for the diagnostic detection of cardiac arrhythmias through a temporary, wearable ECG biosensor. In contrast, Merlin.net provides a platform for clinicians to remotely monitor and manage data from patients with pre-existing implanted cardiac devices. While both operate in cardiology remote monitoring, Zio XT focuses on initial diagnosis, whereas Merlin.net supports ongoing management of implanted devices.

Choose Zio XT ECG Monitoring System if…

Choose Zio XT ECG Monitoring System if you need a comfortable, extended diagnostic tool for patients suspected of intermittent arrhythmias who do not have an implanted cardiac device. This system is ideal for capturing elusive cardiac events over up to 14 days with high patient compliance, leveraging FDA-cleared AI for accurate detection and diagnosis.

View Zio XT ECG Monitoring System →

Choose Merlin.net if…

Choose Merlin.net if you are a clinician managing patients with existing Abbott implanted cardiac devices and require a comprehensive web-based platform for remote follow-up. This tool is best suited for monitoring device performance, receiving alerts for patient events, and streamlining data management and communication for your implanted device patient population.

View Merlin.net →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Zio XT ECG Monitoring System Merlin.net
Pricing Contact for pricing Unknown
Deployment Cloud-based (AWS EC2 platform), no on-premise hardware required. Web-based
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio XT ECG Monitoring System

Zio XT emphasizes patient comfort and ease of use with its wearable, wire-free, water-resistant biosensor, leading to high patient compliance and satisfaction. Merlin.net focuses on clinician-side usability for managing implanted devices, but Zio XT's direct patient experience for monitoring is a stronger differentiator for overall usability of the monitoring system itself.

Clinical Value

Zio XT ECG Monitoring System

Zio XT offers continuous cardiac monitoring for up to 14 days, utilizing FDA-cleared AI for accurate arrhythmia detection and diagnosis, addressing a critical need for identifying new cardiac conditions. While Merlin.net provides valuable remote management for existing implanted devices, Zio XT's primary value lies in its diagnostic capability for previously undiagnosed arrhythmias, potentially leading to earlier intervention.

Pricing & Value

Zio XT ECG Monitoring System

Zio XT provides specific pricing examples for the UK (u00a3310 per patient) and proposed Medicare rates in the US ($229-$260.35), demonstrating transparency and established reimbursement pathways. Merlin.net only states 'contact vendor for pricing,' offering less clarity on its cost structure.

Enterprise Readiness

Merlin.net

Both tools are cloud-based, FDA-cleared, HIPAA compliant, and have BAAs. However, Merlin.net explicitly highlights 'EHRDirectu2122 data transfer for seamless EHR integration (HL7 standards)', which is a crucial feature for enterprise-level data flow and interoperability in healthcare systems. Zio XT mentions EHR integration in its general resources but Merlin.net's explicit mention of HL7 standards gives it an edge here.

Innovation

Zio XT ECG Monitoring System

Zio XT's innovation lies in its wearable, single-lead ECG biosensor providing up to 14 days of continuous monitoring, coupled with a proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis. This represents a significant advancement in non-invasive, long-term diagnostic cardiac monitoring. Merlin.net's innovation is more focused on a comprehensive remote management platform for existing implanted devices.

Support & Docs

Tie

Both iRhythm Technologies and Abbott are major medical device companies expected to offer robust support and documentation. Web searches indicate that both provide extensive manuals, resources, and customer support channels for healthcare professionals and patients. Without specific comparative metrics on the quality or responsiveness of their support, it is difficult to definitively declare a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Zio XT ECG Monitoring System Merlin.net
Tool Name Zio XT ECG Monitoring System Merlin.net
Company iRhythm Technologies Abbott
Core Purpose Wearable, single-lead ECG biosensor for up to 14 days of continuous cardiac monitoring, utilizing FDA-cleared AI and expert review for accurate arrhythmia detection and diagnosis. Web-based remote monitoring platform for clinicians to manage data from patients with implanted cardiac devices, enabling remote follow-up, device performance monitoring, and informed clinical decisions.
Device Type Monitored/Used Wearable single-lead ECG biosensor (Zio biosensor) Abbott implanted cardiac devices
Monitoring Duration Up to 14 days continuous Not specified
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology

Videos

Demos, reviews, and walkthroughs featuring Zio XT ECG Monitoring System and Merlin.net.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Zio XT ECG Monitoring System is designed for patients requiring continuous ambulatory cardiac monitoring for up to 14 days to detect and diagnose arrhythmias. Merlin.net, on the other hand, is a remote monitoring platform specifically for clinicians to manage data from patients with implanted cardiac devices from Abbott.
Zio XT utilizes a wearable, single-lead ECG biosensor that adheres to the patient's chest for continuous external monitoring, without external leads or wires. Merlin.net is a web-based platform that receives and manages data from Abbott's implanted cardiac devices, such as pacemakers and defibrillators.
Zio XT employs a proprietary, FDA-cleared deep-learned AI algorithm for the analysis of ECG data to detect arrhythmias, with expert review by cardiac physiologists. While Merlin.net is categorized under 'Cardiology AI,' its description focuses on data management and review from implanted devices, rather than detailing specific AI-driven analysis of cardiac data from those devices.
Merlin.net features EHRDirectu2122 data transfer, supporting HL7 standards for seamless integration with EHR systems. Zio XT offers EHR integration services to register patients, receive reports, and order monitors directly through the EHR, including specific integration with Epic Aura, which can streamline ordering and make results available in the patient record.
Zio XT is designed for use across Cardiology, Emergency Medicine, and Internal Medicine specialties. Merlin.net is primarily focused on Cardiology, specifically for managing patients with Abbott implanted cardiac devices.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.